F. Colobert et al. / Tetrahedron Letters 48 (2007) 6896–6899
6899
2. (a) Pellissier, H. Tetrahedron 2007, 63, 1297; (b) Hanquet,
21.47 (CH3) 10.35 (CH3). MS (E.I): m/z (%) = 273 (3), 271
(40), 243 (63), 226 (35), 195 (30), 139 (100), 120 (36), 104
(60), 91 (42), 77 (67). HRMS for C14H13N3OS: calcd,
271.0779; found, 271.0778.
´
G.; Colobert, C.; Lanners, S.; Solladie, G. Arkivoc 2003,
vii, 328.
3. (a) Andersen, K. K. Tetrahedron Lett. 1962, 3, 93; (b)
Andersen, K. K.; Gaffield, W.; Papanikolau, N. P.; Foley,
J. W.; Perkins, R. I. J. Am. Chem. Soc. 1964, 86, 5637.
4. Chadlaoui, M.; Abarca, B.; Ballesteros, R.; de Arellano,
13. Abarca, B.; Alkorta, I.; Ballesteros, R.; Blanco, F.;
Chadlaoui, M.; Elguero, J.; Mojarrad, F. Org. Biomol.
Chem. 2005, 3, 3905.
C. R.; Aguilar, J.; Aucejo, R.; Garcia-Espana, E. J. Org.
Chem. 2006, 71, 9030.
5. Jones, G.; Mouat, D. J.; Tonkinson, D. J. Chem. Soc.,
Perkin Trans. 1 1985, 2719.
6. Ballesteros-Garrido, R.; Abarca, B.; Ballesteros, R.;
Leroux, F. R.; Colobert, F., in preparation.
7. (a) Oae, S. Tetrahedron Lett. 1984, 25, 2549; (b) Furuk-
awa, N.; Ogawa, S.; Matsumura, K.; Furihara, Y. H. J.
Org. Chem. 1991, 56, 6341; (c) Vinishi, J.; Tanaka, T.;
Wakabayashi, S.; Oae, S. Tetrahedron Lett. 1990, 31, 4625.
14. 3-[60-(Toluene-4-sulfinyl)-pyridin-20-yl]-[1,2,3]triazolo [1,
5-a]pyridine (1b): mp 167–170 ꢁC. 1H NMR (CDCl3,
300 MHz): d = 8.69 (d, J = 7.0 Hz, 1H), 8.37 (d,
J = 8.9 Hz, 1H), 8.27 (dd, J = 7.2, 1.8 Hz, 1H), 7.91 (dd,
J = 7.1, 7.8 Hz, 1H) 7.88 (dd, J = 7.8, 1.8 Hz, 1H), 7.65 (d,
J = 8.1 Hz, 2H) 7.33 (dd, J = 7.0, 8.9 Hz, 1H), 7.2 (d,
J = 8.1 Hz, 2H), 7.0 (dd, J = 7.0, 6.9 Hz, 1H), 2.30 (s, 3H).
13C NMR (CDCl3, 75.5 MHz): d = 165.00 (C), 152.40 (C),
141.90 (C), 141.26 (C), 138.67 (CH), 136.16 (C), 132.19
(C), 129.93 (CH), 126.96 (CH), 125.42 (CH), 125.35 (CH),
121.19 (CH), 120.84 (CH), 116.74 (CH), 116.05 (CH),
21.82 (CH3). MS (E.I): m/z (%) = 336 (3), 334 (40), 306
(75), 258 (65), 215 (10), 199 (5), 183 (86), 167 (100), 139
(80), 113 (20), 91 (44), 78 (47). HRMS for C18H14N4OS:
calcd, 334.0888; found: 334.0904.
15. 1-(6-(p-Tolylsulfinyl)pyridin-2-yl)ethanone (10): mp 140–
144 ꢁC. 1H NMR (CDCl3, 300 MHz): d = 8.12 (dd,
J = 6.3, 2.7 Hz, 1H), 7.90 (m, 2H), 7.60 (d, J = 8.1 Hz,
2H), 7.17 (d, J = 8.1 Hz, 2H), 2.55 (s, 3H), 2.26 (s, 3H).
13C NMR (CDCl3, 75.5 MHz): d = 198.5, 165.8, 153.1,
141.8, 140.5, 138.9, 129.8, 124.6, 122.1, 121.5, 25.5, 21.3.
HRMS for C14H13NO2S: calcd, 259.0667; found:
259.0669.
˜
`
8. Caupene, C.; Boudou, C.; Perrio, S.; Metzner, P. J. Org.
Chem. 2005, 70, 2812.
9. Maitro, G.; Vogel, S.; Prestat, G.; Madec, D.; Poli, G.
Org. Lett. 2006, 8, 5951.
10. General procedure for palladium-catalyzed arylation of
sulfenate anions under biphasic conditions: To a solution
of Pd2(dba)3 (5 mol %) in toluene (0.500 mL) was added
xantphos (10 mol %). The solution was stirred at room
temperature for 5 min. Then, a solution of hetaryl
bromide (0.5 mmol in 1.5 mL of toluene), b-sulfinylester
(0.7 mmol in 1.5 mL of toluene), distilled water (3.5 mL)
and 50% aq KOH solution (10 mmol) were successively
added. The resulting biphasic system was stirred and
heated to reflux. The reaction was monitored by TLC.
Upon completion of the reaction (2–4 h) and cooling to
room temperature, the aqueous phase was extracted with
dichloromethane (3 · 50 mL). The combined organic lay-
ers were dried over anhydrous MgSO4 and the solvent was
removed under reduced pressure. The crude product was
purified by flash chromatography.
16. 2,6-Bis(p-tolylsulfinyl)pyridine (11): oil. 1H NMR (CDCl3,
300 MHz): d = 8.03 (m, 3H), 7.63/7.43 (d, J = 8.1 Hz,
2H), 7.28/7.10 (d, J = 8.0 Hz, 2H), 2.39/2.36 (s, 6H). 13C
NMR (CDCl3, 75.5 MHz): d = 166.8 (C), 141.9/141.4 (C),
140.4/140.2 (C), 140.0 (CH), 130.0/129.7 (CH), 124.8/
124.7 (CH), 119.3/118.9 (CH), 21.4/21.3 (CH3). HRMS
for C19H17NO2S2: calcd, 355.0701; found, 355.0700.
17. 2,5-Bis(p-tolylsulfinyl)pyridine (12): mp 89–92 ꢁC. 1H
NMR (CDCl3, 300 MHz): d = 8.68/8.66 (m, 1H), 8.12
(m, 2H), 7.63/7.52 (d, J = 8.1 Hz, 2H), 7.29/7.23 (d,
J = 8.1 Hz, 2H), 2.38/2.37 (s, 3H). 13C NMR (CDCl3,
75.5 MHz): d = 168.8/168.7 (C), 146.3, (CH) 144.0/143.8
(C), 142.8/142.7 (C), 142.1/142.0 (C), 140.8/149.7 (C),
140.2/140.1 (C), 134.5/134.4 (CH), 130.5/130.0 (CH),
125.5 (CH), 125.0/124.9 (CH), 119.0/118.9 (CH), 21.5
(CH3), 21.4 (CH3). HRMS for C19H17NO2S2: calcd,
355.0701; found, 355.0703.
11. Abarca, B.; Ballesteros, R.; Jones, G.; Fatemeh, M.
Tetrahedron Lett. 1986, 27, 3543.
12. 3-Methyl-7-(toluene-4-sulfinyl)-[1,2,3]triazolo[1,5-a]pyri-
1
dine (1a): mp 145–147 ꢁC. H NMR (CDCl3, 300 MHz):
d = 7.89 (d, J = 8.2 Hz, 2H), 7.71 (dd, J = 6.9, 1.0 Hz,
1H), 7.65 (dd, J = 8.9, 1.0 Hz, 1H), 7.38 (dd, J = 8.9,
6.9 Hz, 1H), 7.22 (d, J = 8.2 Hz, 2H), 2.58 (s, 3H), 2.30 (s,
3H). 13C NMR (CDCl3, 75.5 MHz): d = 143.04 (C),
141.29 (C), 137.84 (C), 135.19 (C), 132.08 (CH), 129.92
(C), 126.28 (CH), 123.88 (CH), 118.88 (CH), 111.68 (CH),